Portfolio
Look how wonderful work we have done!
Our pharmaceutical subsidiary is dedicated to developing high-quality medications, enhancing health outcomes with research-driven solutions and commitment to patient welfare.
Business Growth
This pharmaceutical unit has interest in constructing a pharmaceutical facility for packaging of finished human formulations at a cost of USD 7.8 million.
This facility will be packaging these formulations at two different sites ,for Beta-lactum and general drugs.
Provisions are also being set for the construction of a production plant in partnership with international investors, this site will be producing drugs from imported Active Pharmaceutical Ingredients (APIs).
- Medical
- Real Madrid C.F
- 24/11/2017
- www.giorf.esp
